Description
Bellast Prime Mild with Lidocaine is a CE-marked hyaluronic acid (HA) dermal filler from the Bellast Prime range by Fox Pharma. It contains 24 mg/mL high-density HA with 0.3% lidocaine, formulated as a viscoelastic gel with uniform particle distribution. The filler is designed for mid-dermal injection, offering moderate volumising and correction — especially suitable for perioral lines, cheeks, and lip augmentation.
What Bellast Prime Mild Is Similar To
Bellast Prime Mild occupies a role similar to mid-viscosity HA fillers used for lip enhancement, cheek volumising, and perioral rejuvenation. For example, compared with lighter fillers aimed at superficial fine lines (akin to a “soft” filler), Bellast Prime Mild offers greater viscoelasticity and deeper dermal support — making it more comparable to standard volumising HA fillers in the mid-dermis. Like other HA fillers, it works through the hydrophilic nature of HA: after injection the gel attracts and retains water, thereby restoring volume, providing structure, and smoothing skin surface. While lighter fillers may primarily address superficial wrinkles, and heavier fillers focus on deep volume or structural contouring, Bellast Prime Mild offers a balance — suitable for moderate volume restoration without overfilling.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to the manufacturer’s product page, Bellast Prime Mild is indicated for:
-
Lips
-
Cheeks
-
Perioral lines
If other areas are considered, verify manufacturer guidance before use.
Usage / Administration (IFU-only)
-
Injection depth: Mid dermis.
-
Syringe & needle gauge: Supplied in a 1 × 1 ml ergonomically designed syringe, with 2 × 27G needles included.
-
Volume per syringe: 1 ml.
-
Frequency / number of sessions: not provided by manufacturer.
-
Professional-use disclaimer: Must be administered by qualified medical professionals under aseptic conditions. (Implicit: product sold to clinics/practitioners only.)
Note: No detailed injection pattern, layering, or retreatment interval is provided in publicly available manufacturer documentation.
Ingredient List
-
Hyaluronic acid — 24 mg/mL (high-density, cross-linked HA)
-
Lidocaine — 0.3% (local anaesthetic for injection comfort)
-
Other excipients / stabilisers / buffers — not provided by manufacturer.
Presentation & Longevity
-
Packaging: 1 × 1 ml pre-filled syringe, supplied with 2 × 27G needles.
-
Longevity / duration of effect: Manufacturer indicates a typical duration of 6–12 months for visible results.
-
Shelf life / storage instructions: not provided on publicly available page — verify on product pack or IFU.
Safety Notes / Contraindications
Manufacturer notes for Bellast Prime Mild with Lidocaine include the following contraindications / precautions:
-
Not to be used in patients with bleeding disorders or on medications affecting platelet function.
-
Should not be re-sterilised, or mixed with other products before injection.
-
Contraindicated in patients with known allergy to lidocaine.
-
Not recommended for patients with susceptibility to keloid formation.
-
Avoid injection at sites with inflammation, infection, or any active skin disease.
-
Not advised for patients who are pregnant or breastfeeding.
If patient has known hypersensitivity to any component (e.g., HA or lidocaine), or active skin infection at the injection site — use is contraindicated.
Regulatory Status
Bellast Prime Mild is CE-marked, confirming conformity with European health, safety, and environmental standards.
No public documentation of UKCA marking, FDA approval, or other regulatory registrations — verify on product pack or official IFU/distributor.
FAQ (5 Evidence-Based Q&As)
Q1: How does Bellast Prime Mild with Lidocaine restore facial volume and improve appearance?
A1: Bellast Prime Mild uses cross-linked hyaluronic acid (24 mg/mL), which when injected into the mid dermis attracts and holds water molecules, thus increasing dermal volume and filling soft-tissue deficits. This provides structural support beneath lips, cheeks, or perioral lines — smoothing wrinkles and restoring a more youthful contour. The viscoelastic gel also integrates into surrounding tissue, leading to natural-looking results.
Q2: Is the injection with Bellast Prime Mild painful?
A2: The filler includes 0.3% lidocaine, a local anaesthetic, which helps minimise discomfort during injection. This tends to make the procedure more comfortable compared with fillers lacking anaesthetic.
Q3: How long do results from Bellast Prime Mild typically last?
A3: According to the manufacturer, visible improvements from a single treatment session generally last between 6 to 12 months. Duration may vary depending on patient skin condition, metabolism, treatment area, and lifestyle.
Q4: What areas of the face can safely be treated with Bellast Prime Mild?
A4: As per manufacturer information, Bellast Prime Mild is intended for lips, cheeks and perioral lines — offering volume restoration and correction in those zones. Use in other areas should only proceed after verifying suitability and practitioner training.
Q5: Is Bellast Prime Mild interchangeable with lighter or heavier fillers in the Bellast Prime range?
A5: Not exactly — Bellast Prime Mild occupies an intermediate role: compared to lighter fillers (designed for fine lines or superficial wrinkles), Mild offers deeper volume support and stronger viscoelasticity; compared to heavier fillers (designed for deep folds, structural contouring), Mild is less robust. Therefore, choosing between Soft, Mild, Hard, or Ultra formulations depends on treatment goals, anatomical area, and required volume.
